CVS HEALTH CORPORATION (CVS)
CVS Health Corporation is a healthcare company that operates the largest pharmacy chain in the United States, offering prescription drugs, health and wellness products, and retail clinics. Founded in 1963, it has expanded to include health insurance services through its acquisition of Aetna, aiming to integrate pharmacy, health, and wellness services for consumers.
Dividend History
Investors can expect a dividend payout of $0.67 per share, scheduled to be distributed in 44 days on November 3, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 3, 2025 | $0.67 | 2025-10-23 | 2025-10-23 |
| August 1, 2025 | $0.67 | 2025-07-22 | 2025-07-22 |
| May 1, 2025 | $0.67 | 2025-04-22 | 2025-04-22 |
| February 3, 2025 | $0.67 | 2025-01-23 | 2025-01-23 |
| November 1, 2024 | $0.67 | 2024-10-21 | 2024-10-21 |
Dividends Summary
- CVS HEALTH CORPORATION has issued 88 dividend payments over the past 21 years
- The most recent dividend was paid 50 days ago, on August 1, 2025
- The highest dividend payed out to investors during this period was $0.665 per share
- The average dividend paid during this period was $0.32 per share.
Company News
HMG Strategy is hosting its 5th Annual Florida C-Level Technology Leadership Summit on September 4, bringing together technology executives to discuss AI, cybersecurity, innovation, and digital transformation strategies.
The Motley Fool is a financial services company founded in 1993, providing investing solutions, market analysis, and financial education to millions of people monthly.
Kite Pharma, a Gilead Sciences subsidiary, acquired Interius BioTherapeutics for $350 million to expand its in vivo CAR T cell therapy capabilities, with the deal expected to slightly reduce 2025 earnings per share.
UnitedHealth Group (UNH) faces regulatory probes, leadership changes, and lawsuits, leading to a 31% stock decline. However, the company's dominant market position, vertically integrated ecosystem, and strong financials suggest it may be too big to break, similar to Boeing's position in the aviation industry.
CVS Health has seen a substantial 24% decline in the past three months, trading below its 50-day and 200-day moving averages. The company is grappling with the industry-wide pharmacy reimbursement crisis and labor shortages, but its 2025 roadmap and strategic initiatives offer a potential pathway to recovery.
